Cargando…

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection

Detalles Bibliográficos
Autores principales:	McGlynn, Fergal, McGrath, Jennifer, Varghese, Chithra, Ryan, Barbara, McHugh, Johnny, Fahy, Arabella, Enright, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443371/ https://www.ncbi.nlm.nih.gov/pubmed/32830309 http://dx.doi.org/10.1007/s11239-020-02251-z

Ejemplares similares

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
por: Bredthauer, Andre, et al.
Publicado: (2020)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia and Renal Insufficiency Undergoing Orthotopic Heart Transplantation
por: Green, Michael Stuart, et al.
Publicado: (2021)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting
por: Klingele, Matthias, et al.
Publicado: (2020)

Argatroban for an alternative anticoagulant in HIT during ECMO
por: Rougé, Alain, et al.
Publicado: (2017)

Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
por: Agarwal, Shvetank, et al.
Publicado: (2012)

Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II
por: Grouzi, Elisavet
Publicado: (2014)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia
por: Ryan, Christine E., et al.
Publicado: (2023)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

Argatroban for anticoagulation of a blood salvage system - an ex-vivo study
por: Beiderlinden, Martin, et al.
Publicado: (2016)

Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis
por: Colarossi, Giorgia, et al.
Publicado: (2021)

A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †
por: Bachler, Mirjam, et al.
Publicado: (2020)

Argatroban for heparin-induced thrombocytopenia therapy in ICU patients with sepsis or multiple organ dysfunction syndrome
por: Saugel, B, et al.
Publicado: (2009)

Successful intravenous administration of argatroban in the management of heparin-resistant and surgery-resistant mesenteric vein thrombosis
por: Yokota, Yuya, et al.
Publicado: (2019)

Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia
por: Marchetti, Matteo, et al.
Publicado: (2022)

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study
por: Fisser, Christoph, et al.
Publicado: (2021)

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
por: Aliter, Kholoud F., et al.
Publicado: (2020)

Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2010)

Successful Management of Heparin-Induced Thrombocytopenia Using Argatroban in a Very Old Woman: A Case Report
por: Putot, A., et al.
Publicado: (2013)

Argatroban caused severe hypercholesterolaemia in a chronic haemodialysis patient with heparin-induced thrombocytopenia: an unreported adverse effect?
por: Nakagawa, Tetsuya
Publicado: (2008)

Correction: Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study
por: Saugel, Bernd, et al.
Publicado: (2012)

Use of Argatroban in Donor Lung Procurement: A Case Report
por: Sharif, Limi, et al.
Publicado: (2021)

Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report
por: Ma, Hongrui, et al.
Publicado: (2023)

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Publicado: (2021)

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Publicado: (2021)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS
por: Brückner, Lea, et al.
Publicado: (2021)

Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
por: Hasan, Haytham, et al.
Publicado: (2023)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

Barriers and enablers to screening and diagnosing depression and diabetes distress in people with type 2 diabetes mellitus; protocol of a qualitative evidence synthesis
por: McGrath, Niamh, et al.
Publicado: (2020)

Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs
por: Lopez, Mercedes, et al.
Publicado: (2012)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

Argatroban Treatment and Decreased Fibrinogen in a Septic Patient
por: Ajmeri, Aman N, et al.
Publicado: (2020)

Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood
por: Hogwood, John, et al.
Publicado: (2020)

Use of argatroban in combination with nafamostat mesilate in open-heart surgery for a pediatric patient with heparin-induced thrombocytopenia type II: a case report
por: Kawamoto, Shuji, et al.
Publicado: (2020)

Low sulfated heparins target multiple proteins for central nervous system repair
por: McCanney, George A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vtq6gufm9k71hilv368ob0m6l3